March 2024 - Page 14 of 18

FridayMar 08, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Banking on DehydraTECH(TM) Technology for Major 2024 Growth

Lexaria, a global innovator in drug delivery platforms, has, since 2016, proven its patented DehydraTECH(TM) technology, asserting its superiority in improving drug bioavailability This has earned it 39 granted patents, with many pending globally DehydraTECH has a number of potential pharmaceutical applications with successful early stage results in hypertension, diabetes and weight loss and many others With its focus on GLP-1 clinical studies for 2024, Lexaria looks to carve out greater market share to make 2024 its biggest year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has been pushing the envelope and redefining drug delivery technology.…

ThursdayMar 07, 2024 3:17 pm

QualityStocksNewsBreaks – GEMXX Corp.’s (GEMZ) Commitment to Quality, Craftmanship and Market Adaptability Expected to Drive Strong Results

GEMXX (OTC: GEMZ), a mine-to-market gold, gemstone and jewelry producer with global reach, recently announced that it is anticipating strong growth over the next 24 months, founding this forecast on the sustained upward trajectory in gold prices and the burgeoning demand for ammolite jewelry. “In the press release announcing the forecast of robust growth, GEMXX describes its entry into gold mining as ‘a new and welcomed asset to the company’s balance sheet,’ with gold adding considerable support to its mine-to-market business model... The press release also describes the growing demand for ammolite jewelry, which has been driven by the rapidly…

ThursdayMar 07, 2024 2:23 pm

QualityStocksNewsBreaks – Correlate Energy Corp. (CIPI) Eyes Opportunity Amid Growing Demand for Decentralized Energy Solutions

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is taking advantage of the increasing shift to renewables across various social and economic sectors as more people come to terms with the reality of climate change. “Over $1.7 trillion worldwide was estimated to be invested in technologies such as wind, solar power, electric vehicles, and batteries in 2023, by far the most ever spent on clean energy in a single year. In addition, the new attention to climate risks, as well as the associated transition to green energy, has been diverse, moving…

ThursdayMar 07, 2024 2:23 pm

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Solutions Offer Greater Online Privacy, Security

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, and its offerings provide key solutions for greater online data privacy required during the current atmosphere of artificial intelligence (“AI”) data harvesting. According to the company, big technology companies are accumulating huge amounts of personal data, often without users' informed consent or knowledge, to train their large language models. This can expose individuals to online privacy risk because the harvesting process might unintentionally capture sensitive information such as names, locations and opinions. In addition, data points can be analyzed by AI models to…

ThursdayMar 07, 2024 1:58 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires CRO for Second DehydraTECH-Powered GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced it has hired a contract research organization (“CRO”) to perform the company’s second DehydraTECH-powered glucagon-like peptide 1 (“GLP-1”) human pilot study #2. According to the announcement, the study will be a randomized, crossover, placebo-controlled investigation that will compare three formulations, each at a 7 mg semaglutide dose: a positive control Rybelsus(R) swallowed tablet; DehydraTECH-semaglutide swallowed capsules; and, for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. “DehydraTECH has previously shown an ability to improve delivery of certain drugs destined for the bloodstream, through the…

ThursdayMar 07, 2024 1:47 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Awarded Two New US Patents Covering Core Cardiac Monitoring Technology

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has received notification that two of its patents covering core vectorelectrocardiography (“VECG”) have been awarded by the United States Patent and Trademark Office. The two new patents bring the total of issued patents in HeartBeam’s portfolio to 14, with four international patents as well; the company also has 20 pending patent applications worldwide. HeartBeam’s VECG technology collects 3D signals of the heart and converts them into a 12-lead ECG. The first awarded patent, “Mobile three-lead cardiac monitoring device and method for automated…

ThursdayMar 07, 2024 1:21 pm

QualityStocksNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR) Announces New Customer in Sober Living Space

SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, has announced a new customer: Breyta House, a sober-living facility located in Houston. The facility empowers women on their journey to recovery and overall wellness. Bretya House will initially be installing SOBRcheck(TM) for point-of-care alcohol screening. Sober-living facilities, or recovery housing, is a recovery support service specifically for those working to recover from substance-use issues. According to the announcement, there are currently an estimated 17,934 recovery homes located in the United States. “With our ability to provide both point-of-care screening and continuous monitoring, we believe that we are uniquely positioned to support…

ThursdayMar 07, 2024 1:08 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Participation at Upcoming 36th Annual Roth Conference

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, and its wholly owned subsidiary Clene Nanomedicine Inc., will be represented at this month’s annual Roth Conference. The conference will be held March 18–19, 2024, in Dana Point, California. According to the announcement, company officials are scheduled to present a fireside chat, slated to begin at 8 a.m. PST on March 18, 2024. Clene focuses on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). An archived version of the presentation will be available following the webcast on the company website.…

ThursdayMar 07, 2024 10:30 am

19th BioPharma Clinical Trials Nexus Conference to Host Industry Leaders Across Europe And Asia

Top executives, middle-level, and senior managers, working in clinical trial operations, outsourcing, digital health, patient engagement, and allied industries in the biopharma spectrum across Europe and North America, are invited to attend the 19th BioPharma Clinical Trials Nexus Conference at the Basel, Mariott Hotel, Switzerland. A prestigious conference, this is an invite-only event featuring top executives and eminent industry leaders. The attendees discuss practical and progressive strategies that pave the path for future trends and outcomes. The platform offers a range of fresh ideas, showcasing the latest technologies and market trends, at a parade of company presentations. Powerful speakers will…

ThursdayMar 07, 2024 9:45 am

Bravo Multinational Inc. (BRVO) Is ‘One to Watch’

Bravo, in February 2024, entered an Asset Purchase Agreement to acquire certain assets of Streaming TVEE Inc. in a deal worth $9.76 million Bravo and Pythia Experiences LLC entered an LOI to form a new company in January 2024, with Pythia owning 51%, Bravo owning 49%, Pythia contributing Vidgo Inc. and Bravo contributing a streaming platform In September 2023, the company announced it would develop an advertising-based video streaming service and app In June 2023, Bravo announced a strategic rebrand, positioning it for growth with a newly defined mission as an entertainment, hospitality and technology company The company in May…

Site Search

Company Search

Month: March 2024